AI-powered gut microbiome mapping could revolutionize cancer detection and transform disease diagnosis.
Scientists at the University of Geneva have created the first detailed catalogue of gut bacteria at the subspecies level, unlocking powerful new ways to detect colorectal cancer. By applying machine learning to stool samples, they achieved a 90% detection rate—nearly matching colonoscopies, but with far less cost and discomfort. This breakthrough could revolutionize early cancer screening, helping catch the disease before it advances.While it has long been known that gut microbiota plays a role in the development of colorectal cancer, translating these findings into clinical practice has proven challenging. This is because different strains of the same bacterial species can have opposite effects, with some promoting the disease and others having no effect.
